PMID- 22268587 OWN - NLM STAT- MEDLINE DCOM- 20120522 LR - 20220321 IS - 1600-0609 (Electronic) IS - 0902-4441 (Linking) VI - 88 IP - 5 DP - 2012 May TI - Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency. PG - 396-405 LID - 10.1111/j.1600-0609.2012.01759.x [doi] AB - OBJECTIVES: In bone marrow, hematopoietic stem cells (HSCs) reside in the most hypoxic endosteum niche, whereas the proliferating progenitors are located near the relatively oxygen-rich vascular region. High oxygen tension is potentially detrimental to HSCs. The objective of this investigation was to compare cellular, functional, and molecular responses of human umbilical cord blood (UCB)-derived hematopoietic stem and progenitor cells in culture under hypoxic and normoxic conditions. METHODS: CD133-enriched UCB cells were cultured in growth factor containing serum-free and serum-supplemented medium under 5% O(2) (hypoxia) or 21% O(2) (normoxia) for 10 d. The phenotypes of expanded cells were analyzed by flow cytometry and the engraftability by SCID-repopulation assay. The expression of hypoxia-inducible factor (HIF)-1alpha and some of its target genes was analyzed by real-time RT-PCR. RESULTS: In hypoxic culture, CD34(+) CD38(-) cells were expanded about 27-fold, which was significantly (P < 0.01) higher than that obtained in normoxic culture. Serum-free culture did not support the growth of cells in the presence of 21% O(2) . Myeloid colony-forming potential of cells was significantly (P < 0.05) increased in 5% O(2) compared with 21% O(2) culture. SCID-repopulation efficiency seems to be better preserved in the cells cultured under hypoxic conditions. Hypoxia significantly (P < 0.05) induced the expression of HIF-1alpha, vascular endothelial growth factor (VEGF), and ABCG2 genes and also upregulated CXCR4 receptor expression. CONCLUSIONS: Low oxygen tension enhanced the proliferation of UCB-derived HSC/progenitor cells and maintenance of SCID-repopulating cells than normoxia. These expanded cells are expected to be beneficial in the patients who lack human leukocyte antigen (HLA)-matched donors. CI - (c) 2012 John Wiley & Sons A/S. FAU - Roy, Sushmita AU - Roy S AD - Stem Cell Biology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India. FAU - Tripathy, Manjul AU - Tripathy M FAU - Mathur, Nitin AU - Mathur N FAU - Jain, Asish AU - Jain A FAU - Mukhopadhyay, Asok AU - Mukhopadhyay A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120217 PL - England TA - Eur J Haematol JT - European journal of haematology JID - 8703985 RN - 0 (ABCG2 protein, human) RN - 0 (AC133 Antigen) RN - 0 (ATP Binding Cassette Transporter, Subfamily G, Member 2) RN - 0 (ATP-Binding Cassette Transporters) RN - 0 (Antigens, CD) RN - 0 (Culture Media) RN - 0 (Glycoproteins) RN - 0 (Neoplasm Proteins) RN - 0 (PROM1 protein, human) RN - 0 (Peptides) RN - 0 (Prom1 protein, mouse) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - AC133 Antigen MH - ATP Binding Cassette Transporter, Subfamily G, Member 2 MH - ATP-Binding Cassette Transporters/metabolism MH - Animals MH - Antigens, CD/immunology MH - Apoptosis MH - Cell Division MH - *Cell Hypoxia MH - Cell Lineage MH - Cell Proliferation MH - Culture Media MH - Fetal Blood/*cytology MH - Flow Cytometry MH - Glycoproteins/immunology MH - Hematopoietic Stem Cells/*cytology/immunology MH - Humans MH - Mice MH - Mice, SCID MH - Neoplasm Proteins/metabolism MH - Peptides/immunology MH - Real-Time Polymerase Chain Reaction MH - Vascular Endothelial Growth Factor A/metabolism EDAT- 2012/01/25 06:00 MHDA- 2012/05/23 06:00 CRDT- 2012/01/25 06:00 PHST- 2012/01/25 06:00 [entrez] PHST- 2012/01/25 06:00 [pubmed] PHST- 2012/05/23 06:00 [medline] AID - 10.1111/j.1600-0609.2012.01759.x [doi] PST - ppublish SO - Eur J Haematol. 2012 May;88(5):396-405. doi: 10.1111/j.1600-0609.2012.01759.x. Epub 2012 Feb 17.